Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures.

We observe the potential confounding effects of tumor purity on GBM clinical and molecular information interpretation. GBM microenvironment could be purity-dependent, which provides new insights into the clinical implications of glioblastoma.